The report also provides a detailed analysis of the current Spinal Stenosis marketed drugs and late-stage pipeline drugs. The increasing cases of traumatic spinal injuries, such as fractures and dislocations, which result in the displacement of bone fragments or misalignment of vertebral structures, are primarily driving the market.